This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Rare Disease Innovation & Partnership Summit
March 21-23, 2023
Delivered as a Hybrid EventPhiladelphia Marriott Downtown

Heather Petty
Director, Program Development at Xontogeny


Heather currently serves as Director of Program Development where she collaborates cross-functionally to construct strategic initiatives and manage priorities across the Xontogeny portfolio. These activities span design and optimization of early preclinical through clinical development, identifying and building upon existing KOL and vendor relationships, and maintaining a pulse on competitive market landscapes. Heather has been with Xontogeny since it was founded in 2016, starting as an Associate with the investment team to support the build out of the company’s due diligence process before moving to portfolio-related activities in 2021.

Heather obtained her MBS degree from Keck Graduate Institute, a specialized program that focuses on translating ideas into commercial products in the biopharmaceutical industry across all modalities and therapeutic areas. She has an entrepreneurial background stemming from several years of breast cancer cell research and the development of a novel diagnostic for early detection of sepsis while acquiring her undergraduate degree at Southwestern University. She is particularly passionate about rare diseases and serves as an advocate through her athletic endeavors on American Ninja Warrior.

Agenda Sessions

  • Optimize Investment Opportunities in Orphan Drugs


Speakers at this event